Nanoscale Horiz., 2021, 6,330-340
DOI: 10.1039/D0NH00624F, Communication
DOI: 10.1039/D0NH00624F, Communication
Byungji Kim, Qinglin Yang, Leslie W. Chan, Sangeeta N. Bhatia, Erkki Ruoslahti, Michael J. Sailor
RNAi-mediated immunotherapy provided by fusogenic porous silicon nanoparticles demonstrates superior therapeutic efficacy against both Gram-positive and Gram-negative bacterial infections compared with first-line antibiotics.
The content of this RSS Feed (c) The Royal Society of Chemistry
RNAi-mediated immunotherapy provided by fusogenic porous silicon nanoparticles demonstrates superior therapeutic efficacy against both Gram-positive and Gram-negative bacterial infections compared with first-line antibiotics.
The content of this RSS Feed (c) The Royal Society of Chemistry